|1.||Hypertension (High Blood Pressure)
07/01/1989 - "This single-blind dose-titration study was designed to determine the therapeutic efficacy, duration of action, and safety profile of tiapamil in patients with essential hypertension. "
08/01/1989 - "Although tiapamil appears to be an effective and well-tolerated drug in mild to moderate hypertension, it failed to reduce left ventricular mass."
03/01/1988 - "Tiapamil appears to be an effective and well-tolerated drug for use in mild to moderately severe hypertension."
08/01/1989 - "Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension."
07/01/1989 - "These results show that tiapamil given at a daily dose of 600-1,200 mg exhibits very little effect in lowering BP in patients with mild to moderate essential hypertension. "
06/01/1985 - "Eleven patients, with recurrent paroxysmal supraventricular tachycardias (PSVT) underwent programmed electrical stimulation of the heart to evaluate the efficacy of intravenous (i.v.) and oral tiapamil in these arrhythmias. "
06/01/1985 - "Effect of i.v. and oral tiapamil in the treatment of paroxysmal supraventricular tachycardia."
01/01/1982 - "Tiapamil may be useful for the termination of reentrant supraventricular tachycardia involving concealed accessory pathways. "
09/01/1979 - "The effect of Ro 11-1781, a drug that affects calcium transport, in 10 patients with paroxysmal supraventricular tachycardia (PSVT), was studied by intracardiac recording and stimulation. "
04/01/1979 - "18 patients with acute myocardial infarction and sustained arrhythmias were treated with a new Ca2+ antagonist, Ro 11-1781, at the dose of 1.0 mg/kg i.v. The drug was effective in reducing heart rate to less than 90 beats/min in 9/10 patients with atrial fibrillation, in 3/4 patients with atrial flutter and in 3/4 patients with supraventricular tachycardia. "
04/01/1983 - "It seems that tiapamil may be beneficial in preventing angina pectoris, but a higher oral dose must be used."
10/01/1986 - "Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris."
04/01/1983 - "Long-term tiapamil treatment of patients with angina pectoris."
09/01/1987 - "This favourable pattern of hemodynamic properties makes tiapamil appear to be a useful agent for the treatment of hypertension and angina pectoris."
01/01/1986 - "The anti-anginal efficacy of tiapamil, a new calcium channel blocking agent was studied in 24 patients with established effort induced chronic stable angina pectoris. "
06/01/1985 - "We have undertaken experimental studies on the anti-arrhythmic properties of tiapamil, and on the intravenous use of this agent in patients with acute myocardial infarction. "
03/01/1986 - "Effect of tiapamil on canine myocardial infarct size."
04/01/1985 - "The hemodynamic effects of this drug (1 mg/kg followed by 25 micrograms/kg/min over 36 hr) were studied in 30 patients randomly assigned in a double-blind manner to a tiapamil or control group within 12 hr of the onset of acute myocardial infarction as diagnosed by Swan-Ganz catheterization and gated blood pool scans. "
01/01/1982 - "We studied the effects of tiapamil during myocardial infarction in the anaesthetized baboon. "
01/01/1982 - "Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon."
|5.||Coronary Artery Disease (Coronary Atherosclerosis)
09/01/1986 - "These antiarrhythmic and haemodynamic effects of tiapamil suggest that this drug would be useful in the management of patients with coronary artery disease."
06/01/1984 - "Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease."
01/01/1982 - "The acute hemodynamic effects of intravenous tiapamil were studied during heart catheterization in 19 patients with coronary artery disease (age range 41-66 years, mean 52.4 years). "
01/01/1982 - "Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease."
01/01/1982 - "Effects of tiapamil on myocardial performance in coronary artery disease."
|2.||Calcium Channels (Calcium Channel)
|9.||Pindolol (LB 46)